Back to Amova Asset Management Americas, Inc. Amova Asset Management Americas, Inc.

ARCTARCT

Showing 8 of 29 quarters

Position history for Amova Asset Management Americas, Inc.Amova Asset Management Americas, Inc.'s holdings in Arcturus Therapeutics Holdings Inc.

Yes. Amova Asset Management Americas holds 1,960,458 shares of ARCT (Arcturus Therapeutics Holdings), worth $13.1M, as of its Q2 2026 13F filing. It reduced the position by 328,477 shares (-14.4%) from Q1 2026. Amova Asset Management Americas has held ARCT since Q2 2019, across 29 quarterly 13F filings. ARCT is 0.2% of Amova Asset Management Americas' reported 13F portfolio.

Current Value

$13.1M

Current Shares

2M

Total Value Change

-$40.6M

Total Shares Change

-354,836

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2M
-14.3%
$13.1M0.2%$6.72
0
2026-Q1
Increased
2.3M
+12.9%
$17.6M0.2%$7.72
38
2025-Q4
Increased
2M
+4.0%
$12.4M0.1%$6.13
35
2025-Q3
Increased
1.9M
+6.4%
$35.9M0.3%$18.43
37
2025-Q2
Decreased
1.8M
-5.0%
$23.8M0.2%$13.01
0
2025-Q1
Decreased
1.9M
-6.7%
$20.4M0.3%$10.59
0
2024-Q4
Decreased
2.1M
-10.8%
$34.9M0.4%$16.97
0
2024-Q3
Increased
2.3M
+48.1%
$53.7M0.6%$23.21
57

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used